ArticleCureus2025
Prevention of Abdominal Ventral Hernia Using a Poly-4-Hydroxybutyrate Monofilament Mesh in Patients Undergoing Ventriculoperitoneal Shunt Placement for Hydrocephalus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The study aimed to evaluate the efficacy of poly-4-hydroxybutyrate (P4HB) monofilament mesh in preventing abdominal ventral hernia and reducing shunt revisions due to catheter migration in patients undergoing ventriculoperitoneal (VP) shunt surgery for hydrocephalus. Methods This retrospective, single-center study included patients who underwent VP shunt surgery for hydrocephalus between 2017 and 2022. Patients were divided into two groups: Group A (no mesh placement) and Group B (mesh placement using P4HB monofilament mesh for hernia prevention). Data were collected and analyzed to assess the outcomes of hernia prevention and shunt revision rates in both groups. Results Among the 46 patients analyzed, Group B (mesh placement) showed a lower incidence of hernia formation and fewer shunt revisions compared to Group A. BMI and recurrence interval were identified as key predictors of shunt revision, with thresholds of 24.05 kg/m² and 17 months demonstrating high sensitivity and specificity. Conclusions The use of P4HB monofilament mesh in VP shunt surgery effectively reduces hernia formation and shunt revisions. Incorporating this mesh into surgical practice may improve outcomes for patients with hydrocephalus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.